Thanks for sharing. I don't think they ever did the wider study extending the pilot, presumably because they came across their own MYC inhibitors.
Would be good to know how their animal test work, based on the above pilot study - i.e. are they comparing their myc fusion in combo with existing drugs against a control group of those existing drugs, or is it something different.
I can only hope they will illuminate us in the coming weeks / months.
Ann: Cell-Penetrating Phylomers Improve Delivery of Drugs-PYC.AX, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |